相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ErbB family receptor inhibitors as therapeutic agents in breast cancer: Current status and future clinical perspective
Ruchi Saxena et al.
MEDICINAL RESEARCH REVIEWS (2012)
The turnover of estrogen receptor α by the selective estrogen receptor degrader (SERD) fulvestrant is a saturable process that is not required for antagonist efficacy
Suzanne E. Wardell et al.
BIOCHEMICAL PHARMACOLOGY (2011)
The IGF Pathway Regulates ERα through a S6K1-Dependent Mechanism in Breast Cancer Cells
Marc A. Becker et al.
MOLECULAR ENDOCRINOLOGY (2011)
Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes
Yinghui Zhang et al.
BREAST CANCER RESEARCH (2011)
Adjuvant aromatase inhibitor therapy: Outcomes and safety
Wolfgang Janni et al.
CANCER TREATMENT REVIEWS (2010)
New Strategies in Estrogen Receptor-Positive Breast Cancer
Stephen R. D. Johnston
CLINICAL CANCER RESEARCH (2010)
Akt2 Inhibition Enables the Forkhead Transcription Factor FoxO3a To Have a Repressive Role in Estrogen Receptor α Transcriptional Activity in Breast Cancer Cells
Catia Morelli et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Responsiveness to PI3K and MEK Inhibitors in Breast Cancer. Use of a 3D Culture System to Study Pathways Related to Hormone Independence in Mice
Maria Laura Polo et al.
PLOS ONE (2010)
Adjuvant Hormonal Therapy for Early-Stage Breast Cancer
Harold J. Burstein et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2010)
Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin
Kathryn E. Vanderlaag et al.
BREAST CANCER RESEARCH (2010)
Igf1r as a therapeutic target in a mouse model of basal-like breast cancer
Apostolos Klinakis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function
Suleiman Massarweh et al.
CANCER RESEARCH (2008)
Targeted therapies in breast cancer: Where are we now?
Serena Di Cosimo et al.
EUROPEAN JOURNAL OF CANCER (2008)
Transcriptional regulation of the cyclin D1 gene at a glance
Eric A. Klein et al.
JOURNAL OF CELL SCIENCE (2008)
A brief introduction to FOXOlogy
Bmth Burgering
ONCOGENE (2008)
Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis
Yiyu Zou et al.
BREAST CANCER RESEARCH (2008)
Definition of functionally important mechanistic differences among selective estrogen receptor down-regulators
Bryan M. Wittmann et al.
CANCER RESEARCH (2007)
Altered target gene regulation controlled by estrogen receptor-α concentration
AM Fowler et al.
MOLECULAR ENDOCRINOLOGY (2006)
RNA interference-mediated depletion phosphoinositide 3-kinase activates forkhead box class O transcription factors and induces cell cycle arrest and apoptosis in breast carcinoma cells
S Reagan-Shaw et al.
CANCER RESEARCH (2006)
p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor α
A Fritah et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1
A Mawson et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2005)
PKB/Akt modulates TGF-β signalling through a direct interaction with Smad3
I Remy et al.
NATURE CELL BIOLOGY (2004)
Akt interacts directly with Smad3 to regulate the sensitivity to TGF-β-induced apoptosis
AR Conery et al.
NATURE CELL BIOLOGY (2004)
Tamoxifen resistance by a conformational arrest of the estrogen receptor α after PKA activation in breast cancer
R Michalides et al.
CANCER CELL (2004)
Mitogenic activity of estrogens in human breast cancer cells does not rely on direct induction of mitogen-activated protein kinase/extracellularly regulated kinase or phosphatidylinositol 3-kinase
AM Gaben et al.
MOLECULAR ENDOCRINOLOGY (2004)
Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: Insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype
J Frasor et al.
ENDOCRINOLOGY (2003)
The cyclin-dependent kinase inhibitor p21CIP/WAF is a positive regulator of insulin-like growth factor I-induced cell proliferation in MCF-7 human breast cancer cells
JL Dupont et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Functional studies of the PI(3)-kinase signalling pathway employing synthetic and expressed siRNA
F Czauderna et al.
NUCLEIC ACIDS RESEARCH (2003)
PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells
G Castoria et al.
EMBO JOURNAL (2001)
Insulin/Insulin-like growth factor-I and estrogen cooperate to stimulate cyclin E-Cdk2 activation and cell cycle progression in MCF-7 breast cancer cells through differential regulation of cyclin E and p21WAF1/Cip1
A Lai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
